| 前收市價 | 1.9800 |
| 開市 | 1.9800 |
| 買盤 | 15.1500 |
| 賣出價 | 15.8000 |
| 拍板 | 2.50 |
| 到期日 | 2024-06-21 |
| 今日波幅 | 1.9800 - 1.9800 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 無 |
Motley FoolIs It Too Late to Buy Novavax Stock?
Shares of the vaccine maker are trading up 230% this year.
Investor's Business DailyThe FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Novavax stock seesawed on June 6 after the FDA assigned an April review date for its Covid vaccine. Is NVAX stock a buy right now?
InvestorPlace3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants
On Friday, the U.S. Federal Drug Administration (FDA) okayed the launch of updated vaccines as part of the 2024-2025 campaign against new Covid strains. Drug manufacturers have been waiting on approval from the agency, whose decision-making was complicated by the fact that the virus keeps mutating. FDA settled on targeting JN.1 — the variant responsible for most Covid cases of early this year. A vaccine targeting JN. 1 should offer broader protection against its offshoots KP.2, KP.3 and others t
